30 August 2019
Visiongain has published a new pharma report Advanced Wound Care Market Forecast 2019-2029: Revenue Prospects by Products for Active Wound Care Dressings (Antimicrobial, Foam, Hydrocolloid, Film, Alginate, Hydrogel, Other), Wound Care Devices (NPWT, Ultrasound, Other) and Wound Care Biologics (Skin Replacement, Collagen-Based, Cell-Based, Other), Applications, End-Users and National Market.
Wound care is essential in improving the quality of life and overall well-being. The wound care industry is highly competitive and diverse with immense potential for growth. Drivers for growth include an increasingly ageing population, rising prevalence of diabetes and obesity, and growing patient awareness.
The number of patients suffering from all forms of chronic wounds is increasing worldwide at around 8% per year; this increasing incidence provides an avenue for substantial growth in the advanced wound care market over the coming years.
This report profiled the selected companies: Acelity, Coloplast, Mölnlycke, Organogenesis, Smith & Nephew, Cardinal Health, BSN Medical GmbH, Hollister, Inc. and other companies.
The lead analyst commented that "The advanced wound care market is expected to experience considerable growth over the forecast period. The main drivers for the growth include an increasingly ageing population, rising prevalence of diabetes and obesity, and growing patient awareness of products available. In the case of patients suffering from chronic wounds, wound care has become a necessity in order to reduce the risk of morbidity.
Due to the maturity of the active wound care dressings market, companies are moving away from the active wound dressings market into wound care devices and biologics. As more companies are entering this market, active wound dressings have become increasingly similar and lacking differentiation."
Notes for Editors If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
About Visiongain Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.
16 September 2020
Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.
14 September 2020
The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.
09 September 2020
The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug discovery. Also, significant growth during the COVID-19 pandemic is expected to be seen in the outsourcing of drugs and medicines needed to treat COVID-19 infections.